GlaxoSmithKline
GSK
$34.90
Share price
-0.43%
Change (1 day)
-19.27%
Change (1 year)
Categories
GlaxoSmithKline (GSK) - Total assets
Total assets on the balance sheet as of December 2022 : $72.89 B
According to GlaxoSmithKline's latest financial reports the company's total assets are $72.89 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
GlaxoSmithKline - Total assets on balance sheet (from 2001 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $72.89 B | -31.73% |
| 2021-12-31 | $106.77 B | -2.61% |
| 2020-12-31 | $109.63 B | 4.91% |
| 2019-12-31 | $104.50 B | 41.78% |
| 2018-12-31 | $73.70 B | -3.28% |
| 2017-12-31 | $76.20 B | 4.45% |
| 2016-12-31 | $72.95 B | -7.88% |
| 2015-12-31 | $79.20 B | 25.14% |
| 2014-12-31 | $63.28 B | -8.83% |
| 2013-12-31 | $69.42 B | 3.56% |
| 2012-12-31 | $67.03 B | 5.2% |
| 2011-12-31 | $63.72 B | -2.25% |
| 2010-12-31 | $65.19 B | -6.01% |
| 2009-12-31 | $69.35 B | 20.13% |
| 2008-12-31 | $57.73 B | -6.35% |
| 2007-12-31 | $61.65 B | 22.87% |
| 2006-12-31 | $50.17 B | 7.33% |
| 2005-12-31 | $46.74 B | 7.9% |
| 2004-12-31 | $43.32 B | 1.16% |
| 2003-12-31 | $42.83 B | 60.19% |
| 2002-12-31 | $26.73 B | 1.65% |
| 2001-12-31 | $26.30 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $117.45 B | 61.12% | 🇨🇭 Switzerland |
 Pfizer PFE | $197.20 B | 170.52% | 🇺🇸 USA |
 Sanofi SNY | $133.42 B | 83.03% | 🇫🇷 France |
 Merck MRK | $109.16 B | 49.74% | 🇺🇸 USA |
 AstraZeneca AZN | $96.48 B | 32.35% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $44.00 B | -39.63% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.98 B | -98.65% | 🇺🇸 USA |